Phase 4 Venous Thromboembolism (VTE) Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Not Yet Recruiting
Phase 4
Coagulation assessment of sublingual oestrogen (CASE) trial comparison of clotting profile and risk in transgender females on oral vs sublingual estrogen for gender affirming hormonal therapy
Gender affirming estrogen therapyVenous Thromboembolism (VTE)
Rita Upreti - Monash health30 enrolled1 locationACTRN12625000730404
Recruiting
Phase 4
Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk
Venous Thromboembolism (VTE)
University Hospital, Brest2,400 enrolled18 locationsNCT06845423
Recruiting
Phase 4
Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis
Intensive Care MedicineVenous ThromboembolismVenous Thromboembolism (VTE)
Science Valley Research Institute50 enrolled1 locationNCT06958588
Completed
Phase 3Phase 4
Assessment of microbleeding after prophylaxis with enoxaparin or rivaroxaban against venous thromboembolic disease following hip and knee surgery
Prevention and treatment of venous thromboembolism (VTE); comprising deep vein thrombosis (DVT) and pulmonary embolism (PE) after hip and knee arthroplasty.
Launceston General Hospital1,060 enrolled1 locationACTRN12609000762257
Recruiting
Phase 4
Thrombophilia in Pregnancy Prophylaxis Study: a multicentre, multinational, randomised controlled trial of prophylactic low molecular weight heparin in high-risk pregnant thrombophilic women.
Venous thromboembolism (VTE) and placenta mediated pregnancy complications in thrombophilic women.
The Ottawa Health Research Institute385 enrolled32 locationsACTRN12608000446369